News
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
A chewing gum impregnated with a plant-grown protein can serve as a “trap” for the SARS-CoV-2 virus, reducing viral load in the chewers saliva and potentially tamping down transmission.
With its highest number of patents issued, commercial agreements, corporate-sponsored research funding, and licensing revenue receipts in a single period, PCI experienced a landmark fiscal year.
Carter Caldwell, the Director of the Penn Medicine Co-Investment Program, wrote a guest blog for Penn Medicine News on how the University has impacted his life as a student, a patient, and an employee
Unique to both Penn and across higher education, the Prize underscores the University’s considerable commitment to encouraging students to put their knowledge to work for the betterment of humankind.
The Penn Biotech Healthcare Consulting Group has a podcast called "Science to Suits" focused on healthcare and biotech commercialization.
VentureWell looks back at launch of the National I-Corps program 10 years ago, and what the program has meant to inventors, researchers, and startups.
The founder, Deboleena (Deb) Dutta graduated from Wharton and participated in the PCI I-Corps program with Viora Health.
Center brings together autoimmune disease researchers and clinicians to advance diagnosis and treatment
A featured story on Katherine Sizov, founder of Strella Biotechnology, and how the company's sensors are reducing food waste and fighting climate change.
President Amy Gutmann has announced the launch of a $750 million investment.